iData Insights

Allergic Rhinitis - Pipeline Review, H2 2015 Now Available at iData Insights

Press Release   •   Jan 30, 2016 13:06 IST

This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Allergic Rhinitis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Allergic Rhinitis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Allergic Rhinitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Allergic Rhinitis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Allergic Rhinitis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Allergic Rhinitis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Browse Complete Report with TOC

To Get Sample Copy of Report visit

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

Global Markets Direct Report Coverage 8

Allergic Rhinitis Overview 9

Therapeutics Development 10

Pipeline Products for Allergic Rhinitis - Overview 10

Pipeline Products for Allergic Rhinitis - Comparative Analysis 11

Allergic Rhinitis - Therapeutics under Development by Companies 12

Allergic Rhinitis - Therapeutics under Investigation by Universities/Institutes 16

Allergic Rhinitis - Pipeline Products Glance 17

Late Stage Products 17

Clinical Stage Products 18

Early Stage Products 19

Allergic Rhinitis - Products under Development by Companies 20

Allergic Rhinitis - Products under Investigation by Universities/Institutes 25

Allergic Rhinitis - Companies Involved in Therapeutics Development 26

3M Drug Delivery Systems 26

3SBio Inc. 27

Accolade Pharma LLC 28

Adamis Pharmaceuticals Corporation 29


ALK-Abello A/S 31

Ampio Pharmaceuticals, Inc. 32

AnaptysBio, Inc. 33

Axikin Pharmaceuticals, Inc. 34

BioTech Tools s.a. 35

Chong Kun Dang Pharmaceutical Corp. 36

ELORAC, Inc. 37

FAES Farma SA 38

Fountain Biopharma Inc. 39

GenMont Biotech Inc. 40

GlaxoSmithKline Plc 41

Glenmark Pharmaceuticals Ltd. 42

GlycoMar Limited 43

HAL Allergy BV 44

Hanmi Pharmaceuticals, Co. Ltd. 45

Hisamitsu Pharmaceutical Co., Inc. 46

Johnson & Johnson 47

Laboratorios LETI S.L. 48

Ligand Pharmaceuticals, Inc. 49

Marinomed Biotechnologie GmbH 50

Merck & Co., Inc. 51

Mitsubishi Tanabe Pharma Corporation 52

Nektar Therapeutics 53

NeoPharm Co., Ltd. 54

Novartis AG 55

Nuvo Research Inc. 56

Oxagen Limited 57

Panmira Pharmaceuticals, LLC. 58

Pfizer Inc. 59

Protectimmun GmbH 60

Regeneron Pharmaceuticals, Inc. 61

Revance Therapeutics, Inc. 62

Roxall Medizin GmbH 63

Sanofi 64

Shionogi & Co., Ltd. 65

Stallergenes S.A. 66

VentiRx Pharmaceuticals, Inc. 67

Xencor, Inc. 68

Ziarco Pharma Ltd 69

Allergic Rhinitis - Therapeutics Assessment 70

Assessment by Monotherapy Products 70

Assessment by Combination Products 71

Assessment by Target 72

Assessment by Mechanism of Action 74

Assessment by Route of Administration 76

Assessment by Molecule Type 78

Read More

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future project.